Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Non-Diabetic Nephrotic Syndrome
NCT05966818Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dapagliflozin in nephrotic syndrome, sponsored by Ain Shams University. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT05966818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05966818.